IRIS

Sfoglia per Rivista  HAEMATOLOGICA

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 64 a 83 di 126
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2019 The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis Mulder, Fi; Candeloro, M; Kamphuisen, Pw; Di Nisio, M; Bossuyt, Pm; Guman, N; Smit, K; Büller, Hr; van Es, N; Abdel-Razeq, H; Ades, S; Ayappan, S; Borchman, S; Cella, C; Fankhauser, C; Ferroni, P; Fuentes, H; Kruger, S; Lim, S; Lubberts, S; Lustig, D; Mansfield, A; Munoz-Martin, A; Noble, S; Panizo, E; Papaxoinis, G; Park, K; Patel, J; Posch, F; Ramos, J; Roselli, M; Fiumara, Sr; Srikanthan, A; Tafur, A; Terbuch, A; Thomas, M; Vathiotis, O; Wang, R; Zahir, M; Sohal, D Articolo su rivista
3-ott-2019 A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia Cohen, Ja; Rossi, Fm; Zucchetto, A; Bomben, R; Terzi-di-Bergamo, L; Rabe, Kg; Degan, M; Steffan, A; Polesel, J; Santinelli, E; Innocenti, I; Cutrona, G; D' Arena, G; Pozzato, G; Zaja, F; Chiarenza, A; Rossi, D; Di Raimondo, F; Laurenti, L; Gentile, M; Morabito, F; Neri, A; Ferrarini, M; Fegan, Cd; Pepper, Cj; Del Poeta, G; Parikh, Sa; Kay, Ne; Gattei, V Articolo su rivista
1-gen-2017 Low dose clofarabine in combination with a standard remission induction in patients 18-60 years with previously untreated intermediate and bad risk AML or high risk MDS:combined Phase I/II results of the EORTC/GIMEMA AML-14A Trial Selleslag, D; Suciu, S; Meloni, G; Muus, P; Halkes, C; Venditti, A; Ramadan, S; Pruijt, H; Meert, L; Vignetti, M; Marie, J; Wittnebel, S; de Witte, T; Amadori, S; Willemze, R; Baron, F Articolo su rivista
1-gen-2008 M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience. Pulsoni, A; Iacobelli, S; Bernardi, M; Borgia, M; Camera, A; Cantore, N; Di Raimondo, F; Fazi, P; Ferrara, F; Leoni, F; Liso, V; Mancini, M; Marmont, F; Matturro, A; Maurillo, L; Melillo, L; Meloni, G; Mirto, S; Specchia, G; Valentini, C; Venditti, A; Leone, G; Foà, R; Mandelli, F; Pagano, L Articolo su rivista
1-gen-2015 Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement Girmenia, C; Viscoli, C; Piciocchi, A; Cudillo, L; Botti, S; Errico, A; Sarmati, L; Ciceri, F; Locatelli, F; Giannella, M; Bassetti, M; Tascini, C; Lombardini, L; Majolino, I; Farina, C; Luzzaro, F; Rossolini, G; Rambaldi, A Articolo su rivista
1-gen-2018 Melphalan 140mg/M2 Or 200mg/M2 For Autologous Transplantation In Myeloma: Results From The Collaboration To Collect Autologous Transplant Outcomes In Lymphoma And Myeloma (CALM) Study. A Report By The EBMT Chronic Malignancies Working Party Auner, H; Iacobelli, S; Sbianchi, G; Knol-Bout, C; Blaise, D; Russell, N; Apperley, J; Pohlreich, D; Browne, P; Kobbe, G; Isaksson, C; Lenhoff, S; Scheid, C; Touzeau, C; Jantunen, E; Anagnostopoulos, A; Yakoub-Agha, I; Tanase, A; Schaap, N; Wiktor-Jedrzejczak, W; Krejci, M; Schönland, S; Morris, C; Garderet, L; Kröger, N Articolo su rivista
1-gen-2017 Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis Buckley, S; Wood, B; Othus, M; Hourigan, C; Ustun, C; Linden, M; Defor, T; Malagola, M; Anthias, C; Valkova, V; Kanakry, C; Gruhn, B; Buccisano, F; Devine, B; Walter, R Articolo su rivista
1-gen-1991 Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients Tribalto, M; Cantonetti, M; Catalano, G; DEL POETA, G; Masi, M; Pastore, S; Pisani, F; Stasi, R; Papa, G Articolo su rivista
1-gen-1991 Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia Zaccaria, A; Tassinari, A; Guerrasio, A; Rosso, C; LO COCO, F; Diverio, D; Testoni, N; Celso, B; Buzzi, M; Tura, S Articolo su rivista
1-gen-2007 Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow Maurillo, L; Buccisano, F; Spagnoli, A; DEL POETA, G; Panetta, P; Neri, B; DEL PRINCIPE, Mi; Mazzone, C; Consalvo, M; Tamburini, A; Ottaviani, L; Fraboni, D; Sarlo, C; DE FABRITIIS, P; Amadori, S; Venditti, A Articolo su rivista
1-giu-2012 Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes. Ferrero, S; Capello, D; Svaldi, M; Boi, M; Gatti, D; Drandi, D; Rossi, D; Barbiero, S; Mantoan, B; Mantella, E; Zanni, M; Ghione, P; Larocca, A; Passera, R; Bertoni, F; Gattei, V; Forconi, F; Laurenti, L; DEL POETA, G; Marasca, R; Cortelazzo, S; Gaidano, G; Palumbo, A; Boccadoro, M; Ladetto, M Articolo su rivista
1-gen-1998 New aspects of immune responses against mycobacteria: immunopharmacology studies Bonmassar, E; Aquino, A; Giuliani, A; Porcelli, S; Tentori, L; Prete, S; Brenner, M; Cirello, I; Cappelletti, D; Graziani, G Articolo su rivista
1-gen-2011 NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotype. Ammatuna, E; Panetta, P; Agirre, X; Ottone, T; Lavorgna, S; Calasanz, M; LO COCO, F Articolo su rivista
1-gen-2008 NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia Falini, B; Mecucci, C; Saglio, G; LO COCO, F; Diverio, D; Brown, P; Pane, F; Mancini, M; Martelli, M; Pileri, S; Haferlach, T; Haferlach, C; Schnittger, S Articolo su rivista
1-mar-2003 One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation Mengarelli, A; Iori, A; Romano, A; Cerretti, R; Cerilli, L; De Propris, M; Fenu, S; Moleti, M; De Felice, L; Girelli, G; Arcese, W Articolo su rivista
1-dic-2006 Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia Buccisano, F; Maurillo, L; DEL POETA, G; Gattei, V; Amadori, S; Venditti, A Articolo su rivista
1-gen-1991 Oral idarubicin plus cytosine arabinoside in the treatment of acute non lymphoblastic leukemia in elderly patients Pagano, L; Sica, S; Marra, R; Voso, Mt; Storti, S; Di Mario, A; Leone, G Articolo su rivista
1-gen-2018 Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation Salvatore, D; Labopin, M; Ruggeri, A; Battipaglia, G; Ghavamzadeh, A; Ciceri, F; Blaise, D; Arcese, W; Socie, G; Bourhis, Jh; Van Lint, Mt; Bruno, B; Huynh, A; Santarone, S; Deconinck, E; Mohty, M; Nagler, A Articolo su rivista
1-nov-2007 Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma Gahrton, G; Iacobelli, S; Bandini, G; Björkstrand, B; Corradini, P; Crawley, C; Hegenbart, U; Morgan, G; Kröger, N; Schattenberg, A; Schönland, So; Verdonck, Lf; Volin, L; de Witte, T; Niederwieser, D Articolo su rivista
1-gen-1990 Peripheral polyneuropathy during treatment with alpha-2 interferon Cudillo, L; Cantonetti, M; Venditti, A; Lentini, R; Rossini, P; Caramia, M; Masi, M; Papa, G Articolo su rivista
Mostrati risultati da 64 a 83 di 126
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile